Napabucasin targets resistant triple negative breast cancer through suppressing STAT3 and mitochondrial function. Yuan L, Zhu Y, Guan G, Liu M, et al. Cancer Chemother Pharmacol 2025;95:51.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yuan L, Zhu Y, Guan G, Liu M, et al. Napabucasin targets resistant triple negative breast cancer through suppressing STAT3 and mitochondrial function. Cancer Chemother Pharmacol 2025;95:51.
PMID: 40169415